Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Favipiravir in high-risk COVID-19 patients
NCT04818320Phase 3Completed
- Sponsor
- Hospital Pulau Pinang
- Start
- Feb 2021
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of favipiravir in coronavirus disease 2019 (COVID-19), sponsored by Hospital Pulau Pinang. Started Feb 2021; status: completed.
02
Drugs
favipiravir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04818320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04818320.